
Company Legal Name
Latest Valuation
Founded Year
Headquarters
Numan operates a digital health platform specializing in personalized treatments for men's health conditions, including erectile dysfunction, hair loss, weight management, and sleep disorders. Founded in 2018 and headquartered in London, the company leverages telemedicine technology to provide discreet, accessible healthcare solutions through its online platform. Numan's approach combines clinical consultations with direct-to-consumer delivery of prescription medications and treatments, addressing traditionally underserved men's health segments. The platform targets the growing telehealth market by focusing specifically on male-oriented health issues that often carry social stigma, positioning itself within the expanding digital healthcare ecosystem serving specialized patient populations.

Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.

Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.


